ArticleCureus2025

Assessment of the Efficacy and Pulmonary Toxicity of Trastuzumab Deruxtecan in HER2-Positive and HER2-Low Metastatic Breast Cancer in a Tertiary Center in the United Arab Emirates.

Mohammad Hourani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.